Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as $25.49 and last traded at $25.47, with a volume of 764095 shares trading hands. The stock had previously closed at $24.87.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the stock. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective on the stock. JMP Securities restated a “market outperform” rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Friday. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. JPMorgan Chase & Co. raised their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Finally, Barclays raised their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $24.94.
Read Our Latest Report on Privia Health Group
Privia Health Group Stock Up 0.4 %
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the stock. First Horizon Advisors Inc. increased its stake in Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after buying an additional 632 shares during the period. EverSource Wealth Advisors LLC increased its stake in Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after buying an additional 2,350 shares during the period. Financial Management Professionals Inc. acquired a new position in Privia Health Group in the 4th quarter valued at approximately $51,000. Quarry LP increased its stake in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares during the period. Finally, KBC Group NV increased its stake in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
- Five stocks we like better than Privia Health Group
- High Flyers: 3 Natural Gas Stocks for March 2022
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Retail Stocks Investing, Explained
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
- What Are Trending Stocks? Trending Stocks Explained
- Analysts See Buying Opportunity in NVIDIA Before Earnings
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.